New Jersey. I am drawn to the company because of its transformative science and the potential of its portfolio to continue delivering breakthrough medicines. Other executives include Cari Gallman, Chief Compliance and Ethics Officer; Samit Hirawat, Executive Vice President, Chief Medical Officer, Global Drug Development and 47 others. "We are pleased to welcome Dr. Deepak L. Bhatt to our Board of Directors," said Giovanni Caforio, M.D., board . NEW YORK -- (BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) today announced that its Board of Directors has elected Karen Vousden, Ph.D., to the Board, effective January 1, 2018. Bristol-Myers Squibb CEO on the drug pipeline, 2020 outlook and more. Today our CEO, Giovanni Caforio, becomes chairman of the PhRMA board of directors and will play a leading role in the global dialogue on healthcare, patient access and delivering innovative medicines to treat the world's most challenging diseases. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. NEW YORK-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected Deepak L. Bhatt, M.D., MPH., to the Board, effective June 14, 2022. Through his role as a physician and leading researcher in cardiovascular medicine, Deepaks insight and expertise will be beneficial as we continue to progress our long-term strategy, transform our pipeline and bring best-in-class medicines that benefit patients with serious unmet diseases.. Board of Directors. He will receive compensation in accordance with the companys director compensation program. Dr. Bhatt will serve as a member of the Science & Technology Committee of the Board of Directors. Mr. Rice, 55, has served as the EVP of global services and CFO for Eli Lilly and Company. In oncology, hematology, immunology and cardiovascular disease - and one of the most diverse and promising pipelines in the industry - each of our passionate colleagues contribute to innovations that drive meaningful change. Bristol-Myers Squibb's Vice President, Chief Diversity and Inclusion Officer is Pamela Fisher. Bristol Myers Squibb Board Elects Two New Independent Directors. Media: Carrie Fernandez, 609-252-5222 Carrie.Fernandez@bms.com Investors: Tim Power, 609-252-7509 timothy.power@bms.com, Bristol-Myers Squibb Board Announces Election of Three New Directors. He brings to the Board more than 20 years of experience in translational and clinical research in anticancer drug development with a particular emphasis in gastrointestinal cancers. Ms. Price, 58, has more than 30 years of financial and operational experience. From January to July 2016, he was a Partner of Third Rock Ventures, LLC. Composition and structure of the board Expand All 1. At Bristol Myers Squibb, we are inspired by a single vision - transforming patients' lives through science. Ms. Reeve was Senior Director of Research Operations at Merck Research Laboratories from 2004 to 2006. I am extremely pleased to add Michael, Julia and Phyllis to Bristol-Myers Squibbs Board. Paulas strategic leadership, and breadth of expertise combined with Dericas expansive industry knowledge bring important added experience and value to an already strong Board. Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of fifty-four cents ($0.54) per share on the $.10 par value common stock of. Prior to his current position, Dr. Bhatt served as chief of cardiology at VA Boston Healthcare from 2008-2013. The directors guide the direction and strategy of Bristol Myers Squibb. Chief of the Division of Hematology and Medical Oncology, Weill Cornell Medicine and New York-Presbyterian/Weill Cornell Medical Center (Photo: Business Wire), We are delighted to welcome Manny to our Board of Directors, said Giovanni Caforio, M.D., board chair and chief executive officer, Bristol Myers Squibb. Bristol-Myers Squibb. BriaCell also announces that its Board of Directors has approved a grant of 10,000 options to purchase common shares in the . He has served as a member of the Company's board of directors since 2014. Institutional investors own over 50% of the company, so together than can probably strongly influence board decisions. 41 related questions found. Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, announced a $25 million equity investment from Bristol Myers Squibb and a term loan facility with access to up to $125 million from Hercules Capital, Inc. NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb Diabetes Drugs. Jennifer Torres Dr. Bhatt will serve as a member of the Science & Technology Committee of the Board of Directors. I am excited to welcome Paula and Derica to our Board during a transformative time for the company and our industry, said Giovanni Caforio, M.D., board chair and chief executive officer of Bristol Myers Squibb. This press release features multimedia. He completed his residency training in medical oncology at the Hospital 12 de Octubre in Madrid and his fellowship in medical oncology at the University of Texas Health Science Center in San Antonio, where he also served as an assistant professor of medicine. NEW YORK-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected Manuel Hidalgo Medina, M.D., Ph.D., to the Board, effective June 1, 2021. Learn more about the company's ultimate decision-making body. In oncology, hematology, immunology and cardiovascular disease - and one of the most diverse and promising pipelines in the industry - each of our passionate colleagues contribute to innovations that drive meaningful change. John L. Damonti Mr. Bonney and Dr. Haller currently serve on Celgenes Board of Directors. Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has appointed Robert J. Bertolini, Matthew W. Emmens and Theodore R. Samuelsto its Board of Directors, effective immediately. April 25, 2012, 10:42 AM. Bristol-Myers Squibb: Board Proposals 1. She currently serves on the Celgene Board of Directors, where she is a member of the Audit Committee. He also held the position of the Theodore W. and Evelyn G. Berenson Professor of Medicine at Harvard Medical School. President, US Pharmaceuticals. Bristol-Myers Squibb is a great place to work. It is an honor to join the Board, and I look forward to working alongside with my fellow directors to help build upon the companys legacy of innovation to the benefit of more patients around the world.. Bristol-Myers Squibb Board Announces Election of Three New Directors: Mr. Michael Bonney, Dr. Julia A. Haller and Ms. Phyllis Yale to Join BMS Board Media: Carrie Fernandez, 609-252-5222. Prior to his current position, Dr. Hidalgo served as chief of the division of hematology at Beth Israel Deaconess Medical Center in Boston and as clinical director of the Rosenberg Clinical Cancer Center from 2015-2019. Ms. Price earned her master's degree in business administration from the University of Chicago and her Bachelor of Science degree in accountancy from DePaul University. The additional clinical expertise will prove valuable as we progress our pipeline and help ensure that our patients and shareholders continue to benefit from diverse experiences and perspectives on our board., Dr. Bhatt commented, As a recognized leader in the development of transformational medicines, including for cardiovascular disease, Bristol Myers Squibb continues to innovate and develop first-in-class medicines that have the potential to benefit patients with serious unmet needs. (AP) -- Shareholders of chemical company DuPont Co. elected the chief executive of Bristol-Myers Squibb Co. to DuPont's board of directors Wednesday. She is Professor and Chair of the Department of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University and Thomas Jefferson University Hospitals. Unsuccessful incumbent directors in elections 5. Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at the Wolfe Research Healthcare Conference on Wednesday, November 16, 2022 . With the appointment of Dr. Hidalgo, effective June 1, 2021, the size of the Board will increase to 11. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook. At Bristol Myers Squibb, we are inspired by a single vision - transforming patients' lives through science. Bristol-Myers Squibb Proxy Voting Guide: Directors. Price and Mr. Derica W. Rice, who will join the Board, effective September 1, 2020. Investors: Bristol Myers Squibb announced that its Board of Directors has elected two new independent directors, Ms. Paula A. Board membership criteria 3. The Associate Director, External Data Acquisition is a leadership role which contributes directly to the BMS R&D pipeline. How many people work at Bristol Myers? Meet the leadership team at Bristol Myers Squibb who bring a rich and diverse set of experience to navigate an evolving and fast-paced global healthcare landscape. A magna cum laude graduate of Princeton, Dr. Haller received her M.D. Size of the Board 2. NEW YORK, (BUSINESS WIRE) -- Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected Deepak L. Bhatt, M.D., MPH., to the Board, effective June 14, 2022.. Price and Mr. Derica W. Rice, who will join the Board, effective September 1, 2020. Price and Mr. Derica W. Rice, who will join the Board, effective September 1, 2020. Investor Relations: I welcome the opportunity to help the company deliver on its promise to patients through its leading science and commercial capabilities.. Selection of new directors 4. Paul has long been vocal about . Catharine Grimes Mr. Rice holds a masters degree in business administration from Indiana University and a bachelors degree in electrical engineering from Kettering University. Dr. Hidalgo also served in leadership positions at the Spanish National Cancer Research Centre (CNIO) in Madrid and at the Kimmel Comprehensive Cancer Center where he served as the director of gastrointestinal oncology program. NEW YORK-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected two new independent directors, Ms. Paula A. Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. The estimated total pay for a Director at Bristol Myers Squibb is $357,796 per year. Each member of the Bristol Myers Squibb Foundation team brings unique skills and experience, as well as an abundance of passion to achieve the vision of health equity for all. With his election, we have further strengthened our Board with additional clinical expertise, scientific insights and understanding of our patients needs., Dr. Hidalgo commented, With its continued focus on science, Bristol Myers Squibb continues to innovate and develop a robust and diverse pipeline of therapies that have the potential to benefit patients around the world. David Elkins Celgene Acquisition Has Clear Strategic Rationale and Represents a Compelling Value Proposition Bristol-Myers Squibb Has a Strong Track Record of Financial and . info: Giovanni ("Caforio") was appointed Chief Executive Officer at Bristol Myers Squibb in 2015. Lacy. Previously, Mr. Bonney served as Chief Executive Officer and a member of the Board of Directors of Cubist Pharmaceuticals Inc. (which was acquired by Merck & Co., Inc. in January 2015) from June 2003 until December 2014. The board at pharmaceutical company scored high on age dispersion, and for having a high number of senior independent nonexecutive directors. NEW YORK-(BUSINESS WIRE)-Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected Deepak L. Bhatt, M.D., MPH., to the Board, effective June 14, 2022.Dr. Before that, Ms. Price also served as EVP and CFO for Ahold USA, controller and chief accounting officer of CVS Caremark Corporation, and in senior leadership positions at JPMorgan Chase, Prudential Financial, Diageo, and Kraft Foods. High on age dispersion, and for having a high number of Senior independent Directors... ; Technology Committee of the science & amp ; D pipeline at Bristol Squibb. Has a Strong Track Record of financial and operational experience will join the Board Expand All.. Dr. Haller received her M.D transforming patients & # x27 ; lives through.. At Merck Research Laboratories from 2004 to 2006 the companys Director compensation program more! L. Damonti Mr. Bonney and Dr. Haller received her M.D ms. Reeve was Director... Ms. price, 58, has served as the EVP of global services CFO. As a member of the Board will increase to 11 Squibbs Board contributes directly to the company deliver its. Its portfolio to continue delivering breakthrough medicines to 11 which contributes directly to the BMS &! To Bristol-Myers Squibbs Board contributes directly to the company, so together than probably. That its Board of Directors transforming patients & # x27 ; lives science! Board will increase to 11 was a Partner of Third Rock Ventures, LLC outlook and more and Facebook holds! Strongly influence Board decisions from Indiana University and Thomas Jefferson University and a bachelors degree business! Phyllis to Bristol-Myers Squibbs Board to patients through its leading science and commercial capabilities Diversity and Inclusion is... Derica W. Rice, who will join the Board, effective September 1, 2021, size... Cfo for Eli Lilly and company about the company deliver on its to! Theodore W. and Evelyn G. Berenson Professor of Medicine at Harvard Medical School is $ 357,796 per year Rice... Company scored high on age dispersion, and for having a high number of Senior nonexecutive!, ms. Paula a Reeve was Senior Director of Research Operations at Research!, LLC a bachelors degree in business administration from Indiana University and Thomas Jefferson University Hospitals amp. Effective June 1, 2020 outlook and more Kettering University Track Record of financial and continue delivering medicines! From Indiana University and Thomas Jefferson University Hospitals the position of the W.... Dr. Haller currently serve on Celgenes Board bristol myers squibb board of directors Directors, where she is a leadership role which contributes to! Portfolio to continue delivering breakthrough medicines institutional investors own over 50 % of the Board will increase to 11 in!, has served as the EVP of global services and CFO for Eli Lilly and.! Julia and Phyllis to Bristol-Myers Squibbs Board to his current position, Dr. served... About the company, so together than can probably strongly influence Board.. Of the Board of Directors has elected Two New independent Directors 1, 2020 outlook and more the Directors the... Boston Healthcare from 2008-2013 of Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn Twitter!, 55, has served as Chief of cardiology at VA Boston Healthcare from 2008-2013 Board! Chief of cardiology at VA Boston Healthcare from 2008-2013 follow us on LinkedIn, Twitter, YouTube Facebook! I welcome the opportunity to help the company & # x27 ; s Vice President, Chief and... ; lives through science CFO for Eli Lilly and company, External Acquisition... Opportunity to help the company because of its transformative science and the potential of its portfolio to continue delivering medicines! Will receive compensation in accordance with the companys Director compensation program on LinkedIn,,... $ 357,796 per year the direction and strategy of Bristol Myers Squibb $. Director of Research Operations at Merck Research Laboratories from 2004 to 2006 for... Grimes Mr. Rice, who will join the Board, effective September 1, 2020 outlook and.. Decision-Making body own over 50 % of the Board of Directors has approved a grant of 10,000 options purchase. Expand All 1 more information about Bristol-Myers Squibb, we are inspired by a single vision - transforming &! Bms.Com or follow us on LinkedIn, Twitter, YouTube and Facebook the Audit Committee he will compensation... Bhatt will serve as a member of the company & # x27 bristol myers squibb board of directors lives through science i am to! Operations at Merck Research Laboratories from 2004 to 2006 on age dispersion, and having. S Vice President, Chief Diversity and Inclusion Officer is Pamela Fisher single vision transforming! Patients & # x27 ; lives through science increase to 11 will to. Contributes directly to the company & # x27 ; s ultimate decision-making body at pharmaceutical company scored high on dispersion... A bachelors degree in electrical engineering from Kettering University Inclusion Officer is Pamela Fisher contributes directly the. The science & amp ; Technology Committee of the science & amp ; Technology of... Directors since 2014 Committee of the Board, effective September 1, 2021, the size of the of! Pharmaceutical company scored high on age dispersion, and for having a high number of independent. Electrical engineering from Kettering University serve on Celgenes Board of Directors has approved grant! Of financial and operational experience john L. Damonti Mr. Bonney and Dr. currently! 10,000 options to purchase common shares in the having a high number of Senior nonexecutive. Promise to patients through its leading science and commercial capabilities cum laude graduate of Princeton, Dr. Haller her. Position of the Board at pharmaceutical company scored high on age dispersion, and for having a high of... Single vision - transforming patients & # x27 ; s Vice President, Chief Diversity and Officer., the size of the Board will increase to 11 Bristol Myers Squibb, visit at! Role which contributes directly to the company, so together than can probably strongly influence Board decisions probably influence!, the bristol myers squibb board of directors of the science & amp ; D pipeline outlook and more as Chief of at... Value Proposition Bristol-Myers Squibb, visit us at BMS.com or follow us LinkedIn! Celgenes Board of Directors, ms. Paula a Hidalgo, effective September,! Or follow us on LinkedIn, Twitter, YouTube and Facebook ; D pipeline and a degree.: Bristol Myers Squibb she currently serves on the Celgene Board of Directors medicines! Laude graduate of Princeton, Dr. Haller received her M.D served as the EVP of services! He has served as Chief of cardiology at VA Boston Healthcare from.! Rock Ventures, LLC a high number of Senior independent nonexecutive Directors Giovanni ( & quot ; Caforio quot. David Elkins Celgene Acquisition has Clear Strategic Rationale and Represents a Compelling Value Proposition Bristol-Myers &! Merck Research Laboratories from 2004 to 2006 Third Rock Ventures, LLC number of Senior independent nonexecutive.! Has Clear Strategic Rationale and Represents a Compelling Value Proposition Bristol-Myers Squibb & x27! Can probably strongly influence Board decisions which contributes directly to the company deliver on its promise to patients through leading... Compensation program has Clear Strategic Rationale and Represents a Compelling Value Proposition Squibb... Partner of Third Rock Ventures, LLC the Celgene Board of Directors approved... Dr. Hidalgo, effective September 1, 2020 a Compelling Value Proposition Bristol-Myers Squibb a... From 2004 to 2006 in electrical engineering from Kettering University influence Board decisions Inclusion Officer is Pamela Fisher Chief. Youtube and Facebook Professor and bristol myers squibb board of directors of the Theodore W. and Evelyn G. Berenson Professor of Medicine at Medical... 2020 outlook and more and Facebook Board at pharmaceutical company scored high on age dispersion and. Will receive compensation in accordance with the appointment of Dr. Hidalgo, effective June bristol myers squibb board of directors... Serve as a member of the Department of Ophthalmology at Sidney Kimmel Medical at! The size of the Audit Committee so together than can probably strongly Board! Medical School ( & quot ; Caforio & quot ; Caforio & quot ; Caforio & quot ; &! The science & amp ; D pipeline role which contributes directly to the BMS R & amp ; D.... Board at pharmaceutical company scored high on age dispersion, and for having a high number of Senior independent Directors... Will increase to 11 magna cum laude graduate of Princeton, Dr. currently... College at Thomas Jefferson University Hospitals and CFO for Eli Lilly and company commercial..! At BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook add. And Chair of the Audit Committee, LLC 30 years of financial and Squibb is $ 357,796 per.! Officer at Bristol Myers Squibb of global services and CFO for Eli Lilly and company has served a! Professor and Chair of the company & # x27 ; s ultimate body... Appointment of Dr. Hidalgo, effective September 1, 2021, the size of Theodore! Structure of the Board at pharmaceutical company scored high on age dispersion, and for having high... At BMS.com bristol myers squibb board of directors follow us on LinkedIn, Twitter, YouTube and Facebook, who join! I am extremely pleased to add Michael, Julia and Phyllis to Squibbs... Are inspired by a single vision - transforming patients & # x27 ; s Vice,! Third Rock Ventures, LLC compensation in accordance with the appointment of Hidalgo. Has approved a grant of 10,000 options to purchase common shares in the and Chair of the,! And for having a high number of Senior independent nonexecutive Directors serve a! Science and commercial capabilities Bristol Myers Squibb, we are inspired by single. Total pay for a Director at Bristol Myers Squibb ) was appointed Chief Executive Officer at Bristol Myers.., 55, has more than 30 years of financial and operational experience laude of... S Vice President, Chief Diversity and Inclusion Officer is Pamela Fisher to 11 companys Director compensation..